Related Experiment Video
Updated: Apr 1, 2026
09:25
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
Published on: May 24, 2020
5.8K
Recombinant Swinepox Virus for Veterinary Vaccine Development
1College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang Rd., Nanjing, Jiangsu, 210095, China. fhj@njau.edu.cn.
Methods in Molecular Biology (Clifton, N.J.)
|October 14, 2015
Summary
Swinepox virus (SPV) shows promise as a recombinant vaccine vector due to its large DNA capacity and ability to elicit immune responses. This makes it suitable for developing vaccines against various diseases.
Area of Science:
- Veterinary Virology
- Vaccine Technology
- Molecular Biology
Background:
- Poxvirus vectors are established tools in vaccine development for human and animal diseases.
- Some poxvirus-based vaccines are already licensed and in widespread use.
Purpose of the Study:
- To highlight the suitability of Swinepox virus (SPV) as a novel vector for recombinant vaccine development.
- To identify key characteristics of SPV that make it advantageous for vaccine design.
Main Methods:
- Review of existing literature on poxvirus vector applications.
- Analysis of Swinepox virus properties relevant to genetic engineering and immunogenicity.
Main Results:
- Swinepox virus possesses a large packaging capacity for recombinant DNA insertions.
- SPV exhibits host range specificity, potentially limiting off-target effects.
- The virus is capable of inducing robust and appropriate immune responses.
Conclusions:
- Swinepox virus is a highly promising candidate for the development of next-generation recombinant vaccines.
- Its unique properties offer significant advantages over existing viral vectors in veterinary and potentially human medicine.
Related Concept Videos
01:23Vaccine Production
57
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
57
00:57Viral Recombination
25.6K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.6K